Vol. 24 No. 2 (2020)
REVIEWS

Non-anaesthetic effects of modern halogen-containing anaesthetics

PDF (Русский)
  • O. Grebenchikov,
  • Yu. Skripkin,
  • O. Gerasimenko,
  • K. Kadantseva,
  • A. Bachinskiy,
  • L. Berikashvili,
  • V. Likhvantsev
O. Grebenchikov
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow
Yu. Skripkin
Moscow Regional Research and Clinical Institute, Moscow
O. Gerasimenko
Moscow Regional Research and Clinical Institute, Moscow
K. Kadantseva
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow
Bio
A. Bachinskiy
Moscow Regional Research and Clinical Institute, Moscow
L. Berikashvili
Moscow Regional Research and Clinical Institute, Moscow
V. Likhvantsev
Moscow Regional Research and Clinical Institute, Moscow
DOI: https://doi.org/10.21688/1681-3472-2020-2-26-45

Published 2020-07-03

Keywords

  • anaesthetic pre-conditioning,
  • isoflurane,
  • halogenated anaesthetics,
  • organ protection,
  • oxidative stress,
  • sevoflurane,
  • systemic inflammatory response syndrome
    • ...More
    Less

How to Cite

Grebenchikov, O., Skripkin, Y., Gerasimenko, O., Kadantseva, K., Bachinskiy, A., Berikashvili, L., & Likhvantsev, V. (2020). Non-anaesthetic effects of modern halogen-containing anaesthetics. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 24(2), 26–45. https://doi.org/10.21688/1681-3472-2020-2-26-45

Copyright (c) 2020 Grebenchikov O.A., Skripkin Yu.V., Gerasimenko O.N., Kadantseva K.K., Bachinskiy A.L., Berikashvili L.B., Likhvantsev V.V.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Many patients undergo surgery under general anaesthesia each day. One of the high-priority tasks for an anesthesiologist is to protect tissues from a systemic inflammatory reaction or oxidative distress (including ischaemia/reperfusion). This review aims to demonstrate the anti-inflammatory and antioxidant properties of general anaesthesia in experimental and clinical studies.
Halogenated anaesthetics lead to the inactivation of glycogen synthase kinase-3β (GSK-3β), a key enzyme in the implementation of cellular damage mechanisms and systemic inflammatory response syndrome (SIRS). These mechanisms are implemented through the transcription factor nuclear factor (NF)-κB. As a result of NF-κB activation, gene expression responsible for proinflammatory cytokine synthesis follows, activating leukocytes and disrupts endothelial cell junctions, leading to a disruption of the endothelial barrier, leukocyte infiltration into tissues, and the development of SIRS. Furthermore, GSK-3β phosphorylation causes an increase in the level in neuronal cells and hepatocytes of transcription factor Nrf2, which is a master regulator of enzyme levels of antioxidant defence in the cell.
Thus, halogenated anaesthetics interfere with different elements responsible for the implementation of SIRS and oxidative distress in addition to limiting disturbing factors during the development of multiorgan failure and endothelial dysfunction in experimental sepsis and a model of ischaemia/reperfusion. Understanding these processes can help to reduce many complications during the post-operative period.

Received 9 January 2020. Revised 6 April 2020. Accepted 7 April 2020.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

Author contributions
Conception and study design: O.A. Grebenchikov, Y.V. Skripkin, V.V. Likhvantsev
Drafting the article: O.A. Grebenchikov, Y.V. Skripkin, O.N. Gerasimenko, K.K. Kadantseva, A.L. Bachinskiy, L.B. Berikashvili,
V.V. Likhvantsev
Critical revision of the article: О.А. Grebenchikov, K.K. Kadantseva
Final approval of the version to be published: O.A. Grebenchikov, Y.V. Skripkin, O.N. Gerasimenko, K.K. Kadantseva,
A.L. Bachinskiy, L.B. Berikashvili, V.V. Likhvantsev

PDF (Русский)

References

  1. Devereaux P.J., Sessler D.I. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373(23):2258-69. PMID: 26630144. https://doi.org/10.1056/NEJMra1502824
  2. Zuo Z. Are volatile anesthetics neuroprotective or neurotoxic? Med Gas Res. 2012;2(1):10. PMID: 22510328. https://doi.org/10.1186/2045-9912-2-10
  3. Li G., Warner M., Lang B.H., Huang L., Sun L.S. Epidemiology of anesthesia-related mortality in the UnitedStates, 1999–2005. Anesthesiology. 2009;110(4):759-65. PMID: 19322941. https://doi.org/10.1097/aln.0b013e31819b5bdc
  4. Kwon J.H., Park J., Lee S.H., Oh A.R., Lee J.H, Min J.J. Effects of volatile versus total intravenous anesthesia on occurrence of myocardial injury after non-cardiac surgery. J Clin Med. 2019;8(11):1199. PMID: 31731805. https://doi.org/10.3390/jcm8111999
  5. Landoni G., Lomivorotov V.V., Nigro Neto C. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N Engl J Med. 2019;380(13):1214-25. PMID: 30888743. https://doi.org/10.1056/NEJMoa1816476
  6. Лихванцев В.В., Скрипкин Ю.В., Ильин Ю.В., Гребенчиков О.А., Шапошников Б.А., Мироненко А.В. Механизмы действия и основные эффекты галогенсодержащих анестетиков. Вестник интенсивной терапии. 2013;(3):44-51. [Likhvantsev V.V., Skripkin Y.V., Il'yin Y.V., Grebenchikov O.A., Shaposhnikov B.A., Mironenko A.V. Mechanisms of action and main effects of halogenated anesthetics. Intensive Care Hirald. 2013;(3):44-51. (In Russ.)]
  7. Pagel P.S., Crystal G.J. The Discovery of myocardial preconditioning using volatile anesthetics: a history and contemporary clinical perspective. J Cardiothorac Vasc Anesth. 2018;32(3):1112-1134. PMID: 29398379. https://doi.org/10.1053/j.jvca.2017.12.029
  8. Bone R.C., Balk R.A, Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-1655. PMID: 1303622. https://doi.org/10.1378/chest.101.6.1644
  9. Rai V., Agrawal D.K. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques. Can J Physiol Pharmacol. 2017;95(10):1245-1253. PMID: 28746820. https://doi.org/10.1139/cjpp-2016-0664
  10. Khosravi A., Mortaz E., Nikaein D., Athari S.S. Role of pathogen-associated molecular patterns (PAMPS) in immune responses to fungal infections. Eur J Pharmacol. 2017;808:8-13. PMID: 27851904. https://doi.org/10.1016/j.ejphar.2016.11.013
  11. Castellheim A., Brekke O.L., Espevik T. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol. 2009;69(6):479-491. PMID: 19439008. https://doi.org/10.1111/j.1365-3083.2009.02255.x
  12. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010:672395. PMID: 20706656. https://doi.org/10.1155/2010/672395
  13. Imaeda A.B. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest. 2009;119(2):305-314. PMID: 19164858. https://doi.org/10.1172/JCI35958
  14. Song D.H., Lee J.O. Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev. 2012;250(1):216-229. PMID: 23046132. https://doi.org/10.1111/j.1600-065X.2012.01167.x
  15. Manickam C., Shah S.V., Lucar O., Ram D.R., Reeves R.K. Cytokine-mediated tissue injury in non-human primate models of viral infections. Front Immunol. 2018;9:2862. PMID: 30568659. https://doi.org/10.3389/fimmu.2018.02862
  16. Jourde-Chiche N., Fakhouri F., Dou L., Bellien J., Burtey S., Frimat M., Jarrot P.A., Kaplanski G., Le Quintrec M., Pernin V., Rigothier C., Sallée M., Fremeaux-Bacchi V., Guerrot D., Roumenina L.T. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15(2):87-108. PMID: 30607032. https://doi.org/10.1038/s41581-018-0098-z
  17. Lee H.T., Kim M., Kim N., Billings F.T. 4th, D'Agati V.D., Emala C.W. Sr. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol. 2007;293(3):F713-722. PMID: 17596528. https://doi.org/10.1152/ajprenal.00161.2007
  18. Huang A.C., Lee T.Y., Ko M.C., Huang C.H., Wang T.Y., Lin T.Y., Lin S.M. Fluid balance correlates with clinical course of multiple organ dysfunction syndrome and mortality in patients with septic shock. PLoS One. 2019;14(12):e0225423. PMID: 31790451. https://doi.org/10.1371/journal.pone.0225423
  19. Peters K., Unger R.E., Brunner J., Kirkpatrick C.J. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003;60(1):49-57. PMID: 14522406. https://doi.org/10.1016/s0008-6363(03)00397-3
  20. Patel K.D., Cuvelier S.L., Wiehler S. Selectins: critical mediators of leukocyte recruitment. Semin Immunol. 2002;14(2):73-81. PMID: 11978079. https://doi.org/10.1006/smim.2001.0344
  21. Alon R., Feigelson S. From rolling to arrest on blood vessels: dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol. 2002;14(2):93-104. PMID: 11978081. https://doi.org/10.1006/smim.2001.0346
  22. Muller W.A., Randolph G.J. Migration of leukocytes across endo thelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol. 1999;66(5):698-704. PMID: 10577496. https://doi.org/10.1002/jlb.66.5.698
  23. Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., Muller W.A. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol. 2002;3(2):143-150. PMID: 11812991. https://doi.org/10.1038/ni749
  24. Barzegar Amiri Olia M., Schiesser C., Taylor M. New reagents for detecting free radicals and oxidative stress. Org Biomol Chem. 2014;12(35):6757-6766. PMID: 25053503. https://doi.org/10.1039/c4ob01172d
  25. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180-183. PMID: 25588755. https://doi.org/10.1016/j.redox.2015.01.002
  26. Гребенчиков О.А., Лихванцев В.В., Плотников Е.Ю. Молекулярные механизмы развития и адресная терапия синдрома ишемии-реперфузии. Анестезиология и реаниматология. 2014;(3):59-67. [Grebenchikov O.A., Likhvantsev V.V., Plotnikov E.Yu., Silachev D.N., Pevzner I.B., Zorova L.D., Zorov D.B. Molecular mechanisms of ischemic-reperfusion syndrome and its therapy. Russian Journal of Anаеsthesiology and Reanimatology = Anesteziologiya i reanimatologiya. 2014;(3):59-67. (In Russ.)]
  27. Cadenas E., Sies H. Oxidative stress: Excited oxygen species and enzyme activity. Adv Enzyme Regul. 1985;23:217-237. PMID: 3907304. https://doi.org/10.1016/0065-2571(85)90049-4
  28. Li C., Jackson R. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282(2):C227-241. PMID: 11788333. https://doi.org/10.1152/ajpcell.00112.2001
  29. Braunwald E., Kloner R. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76(5):1713-1719. PMID: 4056048. https://doi.org/10.1172/JCI112160
  30. Gupta R., Patel A., Shah N., Chaudhary A.K., Jha U.K., Yadav U.C., Gupta P.K., Pakuwal U. Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac J Cancer Prev. 2014;15(11):4405-4409. PMID: 24969860. https://doi.org/10.7314/apjcp.2014.15.11.4405
  31. Noctor G., Lelarge-Trouverie C., Mhamdi A. The metabolomics of oxidativestress. Phytochemistry. 2015;112:33-53. PMID: 25306398. https://doi.org/10.1016/j.phytochem.2014.09.002
  32. Du S.L., Zeng X.Z., Tian J.W., Ai J., Wan J., He J.X. Advanced oxidation protein products in predicting acute kidney injury following cardiac surgery. Biomarkers. 2015;20(3):206-211. PMID: 26154394. https://doi.org/10.3109/1354750X.2015.1062917
  33. Филипповская Ж.С., Герасименко О.Н., Гребенчиков О.А., Зиновкин Р.А., Ларьков Р.Н., Улиткина О.Н., Скрипкин Ю.В., Лихванцев В.В. Оксидантный стресс и ранние осложнения послеоперационного периода в кардиохирургии. Вестник анестезиологии и реаниматологии. 2016;(6):13-21. (Filippovskaya Zh.S., Gerasimenko O.N., Grebenchikov O.А., Zinovkin R.А., Larkov R.N., Ulitkina O.N., Skripkin Yu.V., Likhvantsev V.V. Oxidative stress and early post-operative complications in cardiac surgery. Messenger of Anesthesiology and Resuscitation. 2016;(6):13-21. [(In Russ.)]
  34. Li J.T., Wang H., Li W., Wang L.F., Hou L.C., Mu J.L., Liu X., Chen H.J., Xie K.L., Li N.L., Gao C.F. Anesthetic isoflurane posttreatment attenuates experimental lung injury by inhibiting inflammation and apoptosis. Mediators Inflamm. 2013;2013:108928. PMID: 23710113. https://doi.org/10.1155/2013/108928
  35. Lee Y.M., Song B.C., Yeum K.J. Impact of volatile anesthetics on oxidative stress and inflammation. BioMed Research International. 2015;2015:242709. PMID: 26101769. https://doi.org/10.1155/2015/242709
  36. Jamnicki-Abegg M., Weihrauch D., Pagel P.S., Kersten J.R., Bosnjak Z.J., Warltier D.C., Bienengraeber M.W. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology. 2005;103(5):1006-1014. PMID: 16249675. https://doi.org/10.1097/00000542-200511000-00015
  37. Bedirli N., Bagriacik E.U., Emmez H., Yilmaz G., Unal Y., Ozkose Z. Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia. J Neurosurg Anesthesiol. 2012;24(4):336-344. PMID: 22871953. https://doi.org/10.1097/ANA.0b013e318266791e
  38. Shen X., Bhatt N., Xu J., Meng Т., Aon M.A., O’Rourke B., Berkowitz D.E., Cortassa S., Gao W.D. Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat. J Pharmacol Exp Ther. 2014;349(1):21-28. PMID: 24431470. https://doi.org/10.1124/jpet.113.211144
  39. Mu J., Xie K., Hou L., Peng D., Shang L., Ji G., Li J., Lu Y., Xiong L. Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice. Shock. 2010;34(2):183-189. PMID: 20160672. https://doi.org/10.1097/SHK.0b013e3181cffc3f
  40. Hofstetter C., Boost K.A., Flondor M. Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand. 2007;51(7):893-189. PMID: 17635397. https://doi.org/10.1111/j.1399-6576.2007.01353.x
  41. Plachinta R.V., Hayes J.K., Cerilli L.A., Rich G.F. Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. Anesthesiology. 2003;98(1):89-95. PMID: 12502984. https://doi.org/10.1097/00000542-200301000-00017
  42. Herrmann I.K., Castellon M., Schwartz D.E., Hasler M., Urner M., Hu G., Minshall R.D., Beck-Schimmer B. Volatile anesthetics improve survival after cecal ligation and puncture. Anesthesiology. 2013;119(4):901-906. PMID: 23867232. https://doi.org/10.1097/ALN.0b013e3182a2a38c
  43. Bedirli N., Demirtas C.Y., Akkaya T., Salman B., Alper M., Bedirli A., Pasaoglu H. Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation. J Surg Res. 2012;178(1):e17-23. PMID: 22475355. https://doi.org/10.1016/j.jss.2011.12.037
  44. Dal Molin S.Z., Kruel C.R., de Fraga R.S., Alboim C., de Oliveira J.R., Alvares-da-Silva M.R. Differential protective effects of anaesthesia with sevoflurane or isoflurane:an animal experimental model simulating livert ransplantation. Eur J Anaesthesiol. 2014;31(12):695-700. PMID: 25105848. https://doi.org/10.1097/EJA.0000000000000127
  45. Lee J.J., Li L., Jung H.H., Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology. 2008;108(6):1055-1062. PMID: 18497606. https://doi.org/10.1097/ALN.0b013e3181730257
  46. Reutershan J., Chang D., Hayes J.K., Ley K. Protective effects of isoflurane pretreatment in endotoxin-induced lung. Anesthesiology. 2006;104(3):511-517. PMID: 16508399. https://doi.org/10.1097/00000542-200603000-00019
  47. Chiang N., Schwab Jan M., Fredman G. Anesthetics impact the resolution of inflammation. PLoS One. 2008;3(4):e1879. PMID: 18382663. https://doi.org/10.1371/journal.pone.0001879
  48. Möbert J., Zahler S., Becker B.F., Conzen P.F. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology. 1999;90(5):1372-1381. PMID: 10319786. https://doi.org/10.1097/00000542-199905000-00022
  49. Parker P.J., Caudwell F.B., Cohen P. Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur J Biochem. 1983;130(1):227-234. PMID: 6402364. https://doi.org/10.1111/j.1432-1033.1983.tb07140.x
  50. Juhaszova M., Zorov Dmitry B., Yaniv Y. Role of glycogen synthase kinase-3β in cardioprotection. Circ Res. 2009;104(11):1240-1252. PMID: 19498210. https://doi.org/10.1161/CIRCRESAHA.109.197996
  51. Лихванцев В.В., Гребенчиков О.А., Плотников Е.Ю, Борисов К.Ю, Шайбакова В.Л., Шапошников А.А., Черпаков Р.А., Шмелева Е.В. Механизмы фармакологического прекондиционирования мозга и сравнительная эффективность препаратов - ингибиторов гликоген-синтетазы-киназы-3β прямого и непрямого действия. Общая реаниматология. 2012;8(6):37-42. [Likhvantsev V.V., Grebenchikov O.A., Borisov K.Y., Shaibakova V.L., Shaposhnikov A.A., Cherpakov R.A., Shmeleva E.V. The mechanisms of pharmacological preconditioning of the brain and the comparative efficacy of the drugs — direct- and indirect-acting glycogen synthase kinase-3β inhibitors: experimental study. General Reanimatology. 2012;8(6):37 (In Russ.)]
  52. Гребенчиков О.А., Аврущенко М.Ш., Борисов К.Ю., Ильин Ю.В., Лихванцев В.В. Нейропротекторные эффекты севофлурана на модели тотальной ишемии-реперфузии. Клиническая патофизиология. 2014;(2):57-65. [Grebenchikov O.A., Avrushchenko M.Sh., Borisov K.Yu., Il’yin Yu.V., Likhvantsev V.V. Neuroprotective effects of sevoflurane on the total ischemia-reperfusion model. Clinical Pathophysiology. 2014;(2):57-65. (In Russ.)]
  53. Острова И.В., Гребенчиков О.А., Голубева Н.В. Нейропротективное действие хлорида лития на модели остановки сердца у крыс (экспериментальное исследование). Общая реаниматология. 2019;15(3):73-82. [Ostrova I.V., Grebenchikov O.A., Golubeva N.V. Neuroprotective effect of lithium chloride in rat model of cardiac arrest. General Reanimatology. 2019;15(3):73-82. (In Russ.)]
  54. Борисов К.Ю., Мороз В.В., Гребенчиков О.А., Плотников Е.Ю., Левиков Д.И., Черпаков Р.А., Лихванцев В.В. Влияние пропофола на анестетическое прекондиционирование миокарда севофлураном в эксперименте. Общая реаниматология. 2013;9(4):30-33. [Borisov K.Y., Moroz V.V., Grebenchikov O.A., Plotnikov E.Y., Levikov D.I., Cherpakov R.A., Likhvantsev V.V. Effect of propofol on sevoflurane-induced myocardial preconditioning in the experiment. General Reanimatology. 2013;9(4):30. (In Russ.)]
  55. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000;406(6791):86-90. PMID: 10894547. https://doi.org/10.1038/35017574
  56. Wang H., Kumar A., Lamont R.J., Scott D.A. GSK3β and the control of infectious bacterial diseases. Trends Microbiol. 2014;22(4):208-217. PMID: 24618402. https://doi.org/10.1016/j.tim.2014.01.009
  57. Ko R., Lee S.Y. Glycogen synthase kinase 3β in Toll-like receptor signaling. BMB Rep. 2016;49(6):305-310. PMID: 26996345. https://doi.org/10.5483/BMBRep.2016.49.6.059
  58. Paul J., Naskar K., Chowdhury S., Chakraborti T., De T. TLR mediated GSK3beta activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis. Biochimie. 2014;107 Pt B:235-246. PMID: 25223889. https://doi.org/10.1016/j.biochi.2014.09.004
  59. Rojo A.I., Sagarra M.R., Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem. 2008;105(1):192-202. PMID: 18005231. https://doi.org/10.1111/j.1471-4159.2007.05124.x
  60. Jiang Y., Bao H., Ge Y., Tang W., Cheng D., Luo K., Gong G., Gong R. Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. Gut. 2015;64(1):168-179.306043. PMID: 24811996. https://doi.org/10.1136/gutjnl-2013-306043
  61. Rehm M., Zahler S., Lötsch M., Welsch U., Conzen P., Jacob M., Becker B.F. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004;100(5):1211-23. PMID: 15114220. https://doi.org/10.1097/00000542-200405000-00025
  62. Mulivor A.W., Lipowsky H.H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004;286(5):H1672-1680. PMID: 14704229. https://doi.org/10.1152/ajpheart.00832.2003
  63. Pries A.R., Secomb T.W., Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000;440(5):653-66. PMID: 11007304. https://doi.org/10.1007/s004240000307
  64. Levick J.R., Michel C.C. Microvascular fluid exchange and the revised Starling principle Cardiovasc Res. 2010;87(2):198-210. PMID: 20200043. https://doi.org/10.1093/cvr/cvq062
  65. Zhang Q.H., Sheng Z.Y., Septic Y.M. Septic encephalopathy: when cytokines interact with acetylcholine in the brain. Mil Med Res. 2014;1:20. PMID: 25722876. https://doi.org/10.1186/2054-9369-1-20
  66. Annecke T., Chappell D., Chen C., Jacob M., Welsch U., Sommerhoff C.P., Rehm M., Conzen P.F., Becker B.F. Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. Br J Anaesth. 2010;104(4):414-421. PMID: 20172938. https://doi.org/10.1093/bja/aeq019
  67. Chen C., Chappell D., Annecke T., Conzen P., Jacob M., Welsch U., Zwissler B., Becker B.F. Sevoflurane mitigates shedding of hyaluronan from the coronary endothelium, also during ischemia/reperfusion: an ex vivo animal study. Hypoxia (Auckl). 2016;4:81-90. PMID: 27800510. https://doi.org/10.2147/HP.S98660
  68. Kawamura T., Kadosaki M., Nara N., Kaise A., Suzuki H., Endo S., Wei J., Inada K. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2006;20(4):503-508. PMID: 16884979. https://doi.org/10.1053/j.jvca.2006.01.011
  69. Schilling T., Kozian A., Senturk M., Huth C., Reinhold A., Hedenstierna G., Hachenberg T. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology. 2011;115(1):65-74. PMID: 21399490. https://doi.org/10.1097/ALN.0b013e318214b9de
  70. De Conno E., Steurer M.P., Wittlinger M., Zalunardo M.P., Weder W., Schneiter D., Schimmer R.C., Klaghofer R., Neff T.A., Schmid E.R., Spahn D.R., Z'graggen B.R., Urner M., Beck-Schimmer B. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology. 2009;110(6):1316-1326. PMID: 19417610. https://doi.org/10.1097/ALN.0b013e3181a10731
  71. Fahlenkamp A.V., Coburn M., Rossaint R., Stoppe C., Haase H. Comparison of the effects of xenon and sevoflurane anaesthesia on leucocyte function in surgical patients: a randomized trial. Br J Anaesth. 2014;112(2):272-280. PMID: 24131665. https://doi.org/10.1093/bja/aet330
  72. Kotani, N., Hashimoto H., Sessler D.I., Kikuchi A., Suzuki A., Takahashi S., Muraoka M., Matsuki A. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia Anesthesiology. 1998;89(5):1125-1132. PMID: 9822000. https://doi.org/10.1097/00000542-199811000-00012
  73. Belhomme D., Peynet J., Louzy M., Launay J.M., Kitakaze M., Menasché P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation. 1999;100(19 Suppl):II340-II344. PMID: 10567326. https://doi.org/10.1161/01.cir.100.suppl_2.ii-340
  74. Julier K., da Silva R., Garcia C., Bestmann L., Frascarolo P., Zollinger A., Chassot P.G., Schmid E.R., Turina M.I., von Segesser L.K., Pasch T., Spahn D.R., Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98(6):1315-1327. PMID: 12766638. https://doi.org/10.1097/00000542-200306000-00004
  75. De Hert S.G., ten Broecke P.W., Mertens E., Van Sommeren E.W., De Blier I.G., Stockman B.A., Rodrigus I.E. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002;97(1):42-49. PMID: 12131102. https://doi.org/10.1097/00000542-200207000-00007
  76. De Hert, S.G., Cromheecke S., ten Broecke P.W., Mertens E., De Blier I.G., Stockman B.A., Rodrigus I.E., Van der Linden P.J. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003;99(2):314-23. PMID: 12883404. https://doi.org/10.1097/00000542-200308000-00013
  77. Nader N.D., Li C.M., Khadra W.Z., Reedy R., Panos A.L. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth. 2004;18(3):269-274. PMID: 15232804. https://doi.org/10.1053/j.jvca.2004.03.004
  78. Symons J.A., Myles P.S. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth. 2006;97(2):127-1236. PMID: 16793778. https://doi.org/10.1093/bja/ael149
  79. Landoni G., Biondi-Zoccai G.G., Zangrillo A. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2007;21(4):502-511. PMID: 17678775. https://doi.org/10.1053/j.jvca.2007.02.013
  80. Landoni G., Greco T., Biondi-Zoccai G. Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth. 2013;111(6):886-896. PMID: 23852263. https://doi.org/10.1093/bja/aet231
  81. De Hert S. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia. 2009;64(9):953-60. PMID: 19686479. https://doi.org/10.1111/j.1365-2044.2009.06008.x
  82. Likhvantsev V.V., Landoni G., Levikov D.I., Grebenchikov O.A., Skripkin Y.V., Cherpakov R.A. Sevoflurane versus total intravenous anesthesia for isolated coronary artery bypass surgery with cardiopulmonary bypass: a randomized trial. J Cardiothorac Vasc Anesth. 2016;30(5):1221-1227. PMID: 27431595. https://doi.org/10.1053/j.jvca.2016.02.030
  83. Landoni G., Lomivorotov V.V., Nigro Neto C. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N Engl J Med. 2019;380(13):1214-1225. PMID: 30888743. https://doi.org/10.1056/NEJMoa1816476
  84. Güçlü, Ç.Y., Ünver S., Aydınlı B., Kazancı D., Dilber E., Özgök A. The effect of sevoflurane vs. tiva on cerebral oxygen saturation during cardiopulmonary bypass – randomized trial. Adv Clin Exp Med. 2014;23(6):919-24. PMID: 25618118. https://doi.org/10.17219/acem/37339
  85. Xu J.H., Zhang T.Z., Peng X.F., Jin C.J., Zhou J., Zhang Y.N. Effects of sevoflurane before cardiopulmonary bypass on cerebral oxygen balance and early postoperative cognitive dysfunction. Neurol Sci. 2013;34(12):2123-9. PMID: 23525738. https://doi.org/10.1007/s10072-013-1347-3
  86. Schoen J. Husemann L., Tiemeyer C., Lueloh A., Sedemund-Adib B., Berger K.U., Hueppe M., Heringlake M. Cognitive functione after sevoflurane- vs propofol- based anaesthesia for on-pump cardiac surgery: a randomized controlled trial. Br. J. of Anaesth. 2011;106(6):840-850. PMID: 21518736. https://doi.org/10.1093/bja/aer091
  87. Singh S.P., Kapoor P.M., Chowdhury U., Kiran U. Comparison of S100β levels, and their correlation with hemodynamic indices in patients undegoing coronary artery bypass grafting with three different anesthetic techniques. Ann Card Anaesth. 2011;14:197-202. PMID: 21860192. https://doi.org/10.4103/0971-9784.83998
  88. Борисов К.Ю., Шайбакова В.Л., Черпаков Р.А., Левиков Д.И., Гребенчиков О.А., Лихванцев В.В. Кардио и нейропротекция ингаляционными анестетиками в кардиохирургии. Патология кровообращения и кардиохирургия. 2014;18(3):5-11. [Borisov K.Yu., Shaibakova V.L., Cherpakov R.A., Levikov D.I., Grebenchikov O.A., Likhvantsev V.V. Cardio and neuroprotection with inhalation anesthetics in cardiac surgery. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2014;18(3):5-11. (In Russ.)] http://dx.doi.org/10.21688/1681-3472-2014-3-5-11
  89. Chen F., Duan G., Wu Z., Zuo Z., Li H. Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis. BMJ Open. 2017;7:e014629. PMID:29025825. http://dx.doi.org/10.1136/bmjopen-2016-014629
  90. Sindhvananda W., Phisaiphun K., Prapongsena P. No renal protection from volatileanesthetic preconditioning in open heart surgery. J Anesth. 2013;27:48-55.
  91. Yoo Y.-C., Shim J.-K., Song Y., Yang S.-Y., Kwak Y.-L. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int. 2014;86(2):414-422. PMID: 24429400. http://dx.doi.org/10.1038/ki.2013.532
  92. Li H., Weng Y., Yuan S., Liu W., Yu H., Yu W. Effect of sevoflurane and propofol on acute kidney injury in pediatric living donor liver transplantation. Ann Transl Med. 2019;7(14):340. PMID: 31475210. https://doi.org/10.21037/atm.2019.06.76
  93. Uhlig C., Bluth T., Schwarz K., Deckert S., Heinrich L., De Hert S., Landoni G., Serpa Neto A., Schultz M.J., Pelosi P., Schmitt J., Gama de Abreu M. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis. Anesthesiology. 2016;124(6):1230-45. PMID: 27065094. https://doi.org/10.1097/ALN.0000000000001120
  94. Grabitz S.D., Farhan H.N., Ruscic K.J., Timm F.P., Shin C.H., Thevathasan T., Staehr-Rye A.K., Kurth T., Eikermann M. Dose-dependent protective effect of inhalational anesthetics against postoperative respiratory complications: a prospective analysis of data on file from three hospitals in New England. Crit Care Med. 2017;45(1):e30-39. PMID: 27635768. https://doi.org/10.1097/CCM.0000000000002015
  95. Jabaudon M., Boucher P., Imhoff E., Chabanne R., Faure J.S., Roszyk L., Thibault S., Blondonnet R., Clairefond G., Guérin R., Perbet S., Cayot S., Godet T., Pereira B., Sapin V., Bazin J.E., Futier E., Constantin J.M. Sevoflurane for sedation in acute respiratory distress syndrome. a randomized controlled pilot study. Am J Respir Crit Care Med. 2017;195(6):792-800. PMID: 27611637. https://doi.org/10.1164/rccm.201604-0686OC
  96. Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 2018;16(1):8. PMID: 29347949. https://doi.org/10.1186/s12967-018-1389-7
  97. Gottschalk A., Sharma S., Ford J., Durieux Marcel E., Tiouririne M. Review Article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010;110(6):1636-1643. PMID: 20435944. https://doi.org/10.1213/ANE.0b013e3181de0ab6
  98. Yan T., Zhang G.-H., Wang B.-N., Sun L., Zheng H. Effects of propofol/remifentanil-based total intravenous anesthesia versus sevoflurane-based inhalational anesthesia on the release of VEGF-C and TGF-β and prognosis after breast cancer surgery: a prospective, randomized and controlled study. BMC Anesthesiol. 2018;18(1):131. PMID: 30243294. https://doi.org/10.1186/s12871-018-0588-3